GLP-1 drugs decrease users appetite, which experts previously flagged can lead to micronutrient deficiencies and loss of lean muscle mass
Although anti-CD20 therapy effectively suppresses disease activity, it may trigger reactivation of latent infections (e.g., tuberculosis, hepatitis) and infusion-related reactions (e.g., fever, headache) (57)
Who can you call or contact if there are concerns or questions
Metabolic Health Benefits Beyond weight loss, retatrutide improved glycemic control, reduced liver fat (by up to 81% in trial participants), lowered triglycerides, and improved multiple cardiometabolic markers
Pu Z, Yang Y, Qin S, Li X, Cui C, Chen W